We are live on ! Find out more
CT

Clearstead Trust Portfolio holdings

AUM $765M
1-Year Est. Return 36.91%
This Fund
S&P 500
This Quarter Est. Return
-3.46%
1 Year Est. Return
+36.91%
3 Year Est. Return
+111.44%
5 Year Est. Return
+150.49%
10 Year Est. Return
AUM
$304M
AUM Growth
-$7.39M
Cap. Flow
+$229K
Cap. Flow %
0.08%
Top 10 Hldgs %
55.05%
Holding
463
New
73
Increased
128
Reduced
54
Closed
16

Top Buys

Rank Stock Value
1
QLD icon
ProShares Ultra QQQ
QLD
+$3.81M
2
NVDA icon
NVIDIA
NVDA
+$2.42M
3
LIN icon
Linde
LIN
+$1.99M
4
ADP icon
Automatic Data Processing
ADP
+$1.92M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.72M

Top Sells

Rank Stock Value
1
ILCG icon
iShares Morningstar Growth ETF
ILCG
+$9.97M
2
DHR icon
Danaher
DHR
+$2.41M
3
MCD icon
McDonald's
MCD
+$2.12M
4
NEM icon
Newmont
NEM
+$1.68M
5
AMT icon
American Tower
AMT
+$1.63M

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.93%
2 Technology 17.59%
3 Healthcare 9.18%
4 Financials 5.95%
5 Consumer Discretionary 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRU icon
376
Prudential Financial
PRU
$41.2B
$5.6K ﹤0.01%
59
MTN icon
377
Vail Resorts
MTN
$4.92B
$5.55K ﹤0.01%
+25
New +$5.93K
RWX icon
378
State Street SPDR Dow Jones International Real Estate ETF
RWX
$255M
$5.4K ﹤0.01%
227
PLD icon
379
Prologis
PLD
$129B
$5.27K ﹤0.01%
47
NFG icon
380
National Fuel Gas
NFG
$7.77B
$5.24K ﹤0.01%
+101
New +$5.32K
CRSP icon
381
CRISPR Therapeutics
CRSP
$5.01B
$5.22K ﹤0.01%
+115
New +$5.94K
BPMC
382
DELISTED
Blueprint Medicines
BPMC
$5.07K ﹤0.01%
101
NBIX icon
383
Neurocrine Biosciences
NBIX
$15.2B
$4.95K ﹤0.01%
+44
New +$4.63K
UCON icon
384
First Trust Smith Unconstrained Bond ETF
UCON
$3.26B
$4.92K ﹤0.01%
206
STZ icon
385
Constellation Brands
STZ
$21.1B
$4.78K ﹤0.01%
19
ACHC icon
386
Acadia Healthcare
ACHC
$2.55B
$4.5K ﹤0.01%
+64
New +$4.78K
AMJ
387
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$4.37K ﹤0.01%
177
FUN icon
388
Cedar Fair
FUN
$1.3B
$4.25K ﹤0.01%
115
KMB icon
389
Kimberly-Clark
KMB
$32.8B
$4.23K ﹤0.01%
35
DNA icon
390
Ginkgo Bioworks
DNA
$471M
$4.21K ﹤0.01%
+58
New +$4.64K
SLAB icon
391
Silicon Laboratories
SLAB
$7.34B
$4.17K ﹤0.01%
+36
New +$4.97K
BXP icon
392
Boston Properties
BXP
$10.2B
$4.11K ﹤0.01%
69
LBRDA
393
DELISTED
Liberty Broadband Class A
LBRDA
$3.82K ﹤0.01%
42
FTEC icon
394
Fidelity MSCI Information Technology Index ETF
FTEC
$20.8B
$3.69K ﹤0.01%
30
DOC icon
395
Healthpeak Properties
DOC
$13.9B
$3.67K ﹤0.01%
200
CMG icon
396
Chipotle Mexican Grill
CMG
$44.1B
$3.66K ﹤0.01%
100
BATRK icon
397
Atlanta Braves Holdings Series B
BATRK
$3.25B
$3.57K ﹤0.01%
+100
New +$3.79K
FIDU icon
398
Fidelity MSCI Industrials Index ETF
FIDU
$2.19B
$3.41K ﹤0.01%
63
DD icon
399
DuPont de Nemours
DD
$17.3B
$3.36K ﹤0.01%
36
BJ icon
400
BJs Wholesale Club
BJ
$12B
$3.25K ﹤0.01%
+51
New +$3.43K

Similar funds

Clearstead Trust's Q3 2023 Portfolio in Review

As of Q3 2023, Clearstead Trust held 463 positions worth $304M, down 2.4% from $311M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Clearstead Trust's Q3 2023 filing shows 73 new, 128 increased, 54 reduced and 16 closed positions. Its largest new stake was Vanguard Morningstar Growth ETF: 1,884 shares worth $85.5K. The largest sale was iShares Morningstar Growth ETF, an estimated $9.97M.

By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, down from 44% a quarter earlier, followed by Technology and Healthcare.

  • Clearstead Trust's largest Q3 2023 buy was Vanguard Morningstar Growth ETF: 1,884 shares worth $85.5K.
  • Clearstead Trust added most to ProShares Ultra QQQ in Q3 2023, an estimated $3.81M increase.
  • Clearstead Trust's biggest Q3 2023 reduction was iShares Morningstar Growth ETF, cutting an estimated $9.97M.
  • Clearstead Trust fully exited United Rentals in Q3 2023, selling an estimated $969K.
  • Clearstead Trust's ten largest holdings make up 55% of its $304M portfolio in Q3 2023.
  • Clearstead Trust opened 73 new positions and closed 16 in Q3 2023.
  • Clearstead Trust's portfolio value fell 2.4% quarter-over-quarter to $304M.

Based on Clearstead Trust's 13F filing for Q3 2023, filed 13 Nov 2023.